| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 8.60e-05 | 18 | 97 | 3 | GO:0008569 | |
| GeneOntologyCellularComponent | 3M complex | 2.11e-04 | 5 | 97 | 2 | GO:1990393 | |
| GeneOntologyCellularComponent | eukaryotic translation initiation factor 2 complex | 3.16e-04 | 6 | 97 | 2 | GO:0005850 | |
| Domain | Leu-rich_rpt | LGR4 LRRC4C OMG LRIG2 NOD1 LRRIQ1 LRRC25 TLR4 CD180 LRRC18 GP1BA | 1.45e-07 | 271 | 96 | 11 | IPR001611 |
| Domain | Leu-rich_rpt_typical-subtyp | 3.21e-07 | 177 | 96 | 9 | IPR003591 | |
| Domain | LRR_TYP | 3.21e-07 | 177 | 96 | 9 | SM00369 | |
| Domain | - | LGR4 LRRC4C OMG LRIG2 NOD1 LRRIQ1 LRRC25 TLR4 CD180 LRRC18 GP1BA | 7.83e-07 | 321 | 96 | 11 | 3.80.10.10 |
| Domain | LRR | 9.36e-07 | 201 | 96 | 9 | PS51450 | |
| Domain | L_dom-like | LGR4 LRRC4C OMG LRIG2 NOD1 LRRIQ1 LRRC25 TLR4 CD180 LRRC18 GP1BA | 9.68e-07 | 328 | 96 | 11 | IPR032675 |
| Domain | LRR_8 | 2.80e-06 | 171 | 96 | 8 | PF13855 | |
| Domain | LRR_1 | 1.72e-05 | 219 | 96 | 8 | PF00560 | |
| Domain | Dynein_HC_stalk | 4.60e-05 | 14 | 96 | 3 | IPR024743 | |
| Domain | MT | 4.60e-05 | 14 | 96 | 3 | PF12777 | |
| Domain | DHC_fam | 5.73e-05 | 15 | 96 | 3 | IPR026983 | |
| Domain | Dynein_heavy_dom | 5.73e-05 | 15 | 96 | 3 | IPR004273 | |
| Domain | Dynein_heavy | 5.73e-05 | 15 | 96 | 3 | PF03028 | |
| Domain | Cys-rich_flank_reg_C | 1.01e-04 | 90 | 96 | 5 | IPR000483 | |
| Domain | LRRCT | 1.01e-04 | 90 | 96 | 5 | SM00082 | |
| Domain | LRRNT | 1.58e-04 | 53 | 96 | 4 | PF01462 | |
| Domain | LRRCT | 5.86e-04 | 32 | 96 | 3 | PF01463 | |
| Domain | U-box | 7.17e-04 | 8 | 96 | 2 | PF04564 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 7.64e-04 | 35 | 96 | 3 | IPR002464 | |
| Domain | DEAH_ATP_HELICASE | 9.74e-04 | 38 | 96 | 3 | PS00690 | |
| Domain | Ubox_domain | 1.15e-03 | 10 | 96 | 2 | IPR003613 | |
| Domain | P-loop_NTPase | MPP3 DNHD1 EP400 CHD1 DNAH14 GFM2 DHX30 NOD1 LRRIQ1 EIF2S3 NAV2 DNAH6 | 1.33e-03 | 848 | 96 | 12 | IPR027417 |
| Domain | - | MPP3 DNHD1 EP400 CHD1 DNAH14 GFM2 DHX30 NOD1 EIF2S3 NAV2 DNAH6 | 1.54e-03 | 746 | 96 | 11 | 3.40.50.300 |
| Domain | LRRNT | 1.64e-03 | 98 | 96 | 4 | IPR000372 | |
| Domain | LRRNT | 1.64e-03 | 98 | 96 | 4 | SM00013 | |
| Domain | ARM-type_fold | 1.83e-03 | 339 | 96 | 7 | IPR016024 | |
| Domain | Dynein_heavy_chain_D4_dom | 2.29e-03 | 14 | 96 | 2 | IPR024317 | |
| Domain | Dynein_heavy_dom-2 | 2.29e-03 | 14 | 96 | 2 | IPR013602 | |
| Domain | DHC_N2 | 2.29e-03 | 14 | 96 | 2 | PF08393 | |
| Domain | AAA_8 | 2.29e-03 | 14 | 96 | 2 | PF12780 | |
| Domain | ARM-like | 2.70e-03 | 270 | 96 | 6 | IPR011989 | |
| Domain | Rib_L2_dom2 | 3.79e-03 | 18 | 96 | 2 | IPR014722 | |
| Domain | - | 3.79e-03 | 18 | 96 | 2 | 2.30.30.30 | |
| Domain | EFTu-like_2 | 3.79e-03 | 18 | 96 | 2 | IPR004161 | |
| Domain | GTP_EFTU_D2 | 3.79e-03 | 18 | 96 | 2 | PF03144 | |
| Domain | G_TR_2 | 3.79e-03 | 18 | 96 | 2 | PS51722 | |
| Domain | TF_GTP-bd_dom | 4.22e-03 | 19 | 96 | 2 | IPR000795 | |
| Domain | BRCT | 4.22e-03 | 19 | 96 | 2 | PF00533 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | CENPT EP400 RBBP6 NOL6 TOPBP1 EIF2S3B CHD1 MED19 EIF2S3 SENP6 KMT2A PCBP2 CUX1 TP53BP1 KNL1 | 9.70e-08 | 954 | 100 | 15 | 36373674 |
| Pubmed | 2.73e-07 | 222 | 100 | 8 | 37071664 | ||
| Pubmed | EP400 TTC28 UBE4B SMURF1 TNRC6B LRRC4C DHX30 UBR5 PDE4DIP DISP2 | 2.93e-07 | 407 | 100 | 10 | 12693553 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MPP3 SEMA6C EP400 PCNX3 UBE4B OBSCN DHX30 INF2 CCDC34 NAV2 ULK4 DISP2 ESPL1 TTC38 IL4R | 6.28e-07 | 1105 | 100 | 15 | 35748872 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | EP400 TTC28 RBBP6 TOPBP1 E2F3 CUL7 UBR5 SENP6 PCBP2 TP53BP1 KNL1 | 1.07e-06 | 588 | 100 | 11 | 38580884 |
| Pubmed | EP400 PCNX3 RBBP6 NOL6 TOPBP1 TNRC6B CHD1 TEX10 DHX30 MED19 UTS2 EIF2S3 SEC24B KMT2A EXOC2 CNOT2 EPB41L2 | 1.23e-06 | 1497 | 100 | 17 | 31527615 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | EP400 RBBP6 TNRC6B CHD1 DHX30 EIF2S3 SEC24B SENP6 KMT2A PCBP2 EPB41L2 TP53BP1 KNL1 | 2.87e-06 | 934 | 100 | 13 | 33916271 |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 6.69e-06 | 341 | 100 | 8 | 32971831 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 23844130 | ||
| Pubmed | Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105. | 8.18e-06 | 2 | 100 | 2 | 15852007 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 30756214 | ||
| Pubmed | Bronchial inflammation and bacterial load in stable COPD is associated with TLR4 overexpression. | 8.18e-06 | 2 | 100 | 2 | 28536249 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 26915562 | ||
| Pubmed | Characterization of the MLL partner gene AF15q14 involved in t(11;15)(q23;q14). | 8.18e-06 | 2 | 100 | 2 | 12618768 | |
| Pubmed | Nutlin-Induced Apoptosis Is Specified by a Translation Program Regulated by PCBP2 and DHX30. | 8.18e-06 | 2 | 100 | 2 | 32234473 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 24882704 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 32412103 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 27934908 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 31135337 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 31724242 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 30639993 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 31590042 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 30710046 | ||
| Pubmed | A key role for the endothelium in NOD1 mediated vascular inflammation: comparison to TLR4 responses. | 8.18e-06 | 2 | 100 | 2 | 22870324 | |
| Pubmed | RP105 deficiency aggravates cardiac dysfunction after myocardial infarction in mice. | 8.18e-06 | 2 | 100 | 2 | 25156852 | |
| Pubmed | Sexually dimorphic expression of the X-linked gene Eif2s3x mRNA but not protein in mouse brain. | 8.18e-06 | 2 | 100 | 2 | 16325480 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 20404812 | ||
| Pubmed | 1.02e-05 | 15 | 100 | 3 | 16622420 | ||
| Pubmed | 1.13e-05 | 101 | 100 | 5 | 10997877 | ||
| Pubmed | EP400 TTC28 NOL6 LGR4 TNRC6B LRIG2 UBR5 EIF2S3 SEC24B CUX1 EPB41L2 | 1.50e-05 | 777 | 100 | 11 | 35844135 | |
| Pubmed | 1.80e-05 | 282 | 100 | 7 | 23667531 | ||
| Pubmed | 1.96e-05 | 55 | 100 | 4 | 34237211 | ||
| Pubmed | 2.21e-05 | 116 | 100 | 5 | 30804394 | ||
| Pubmed | 2.27e-05 | 529 | 100 | 9 | 14621295 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 20430725 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 23727510 | ||
| Pubmed | A t(11;15) fuses MLL to two different genes, AF15q14 and a novel gene MPFYVE on chromosome 15. | 2.45e-05 | 3 | 100 | 2 | 12618766 | |
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 25218901 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 17309748 | ||
| Pubmed | RP105 involved in activation of mouse macrophages via TLR2 and TLR4 signaling. | 2.45e-05 | 3 | 100 | 2 | 23483427 | |
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 32521253 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 20649597 | ||
| Pubmed | Peptidoglycan from the gut microbiota governs the lifespan of circulating phagocytes at homeostasis. | 2.45e-05 | 3 | 100 | 2 | 26989200 | |
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 29030987 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 38363110 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 22046413 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 23203928 | ||
| Pubmed | Amelioration of the macrothrombocytopenia associated with the murine Bernard-Soulier syndrome. | 2.45e-05 | 3 | 100 | 2 | 12200373 | |
| Pubmed | A DNA damage-regulated BRCT-containing protein, TopBP1, is required for cell survival. | 2.45e-05 | 3 | 100 | 2 | 11756551 | |
| Pubmed | Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. | 2.45e-05 | 3 | 100 | 2 | 20081863 | |
| Pubmed | Epigenetic Regulation of TLR4 in Diabetic Macrophages Modulates Immunometabolism and Wound Repair. | 2.45e-05 | 3 | 100 | 2 | 32205424 | |
| Pubmed | Mus spretus SEG/Pas mice resist virulent Yersinia pestis, under multigenic control. | 2.45e-05 | 3 | 100 | 2 | 20861861 | |
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 17964870 | ||
| Pubmed | Variation in Cilia Protein Genes and Progression of Lung Disease in Cystic Fibrosis. | 2.45e-05 | 3 | 100 | 2 | 29323929 | |
| Pubmed | 3.04e-05 | 549 | 100 | 9 | 38280479 | ||
| Pubmed | 3.35e-05 | 210 | 100 | 6 | 16565220 | ||
| Pubmed | A new mechanism for inhalational priming: IL-4 bypasses innate immune signals. | 4.89e-05 | 4 | 100 | 2 | 18981153 | |
| Pubmed | 4.89e-05 | 4 | 100 | 2 | 22354914 | ||
| Pubmed | 4.89e-05 | 4 | 100 | 2 | 26831416 | ||
| Pubmed | 4.89e-05 | 4 | 100 | 2 | 23589304 | ||
| Pubmed | Suppression of MEHMO Syndrome Mutation in eIF2 by Small Molecule ISRIB. | 4.89e-05 | 4 | 100 | 2 | 31836389 | |
| Pubmed | 4.89e-05 | 4 | 100 | 2 | 23399917 | ||
| Pubmed | 4.89e-05 | 4 | 100 | 2 | 31099187 | ||
| Pubmed | An unusual dimeric structure and assembly for TLR4 regulator RP105-MD-1. | 4.89e-05 | 4 | 100 | 2 | 21857663 | |
| Pubmed | The toll-like receptor protein RP105 regulates lipopolysaccharide signaling in B cells. | 4.89e-05 | 4 | 100 | 2 | 10880523 | |
| Pubmed | 4.89e-05 | 4 | 100 | 2 | 20233331 | ||
| Pubmed | 4.89e-05 | 4 | 100 | 2 | 25611587 | ||
| Pubmed | 5.36e-05 | 591 | 100 | 9 | 15231748 | ||
| Pubmed | 6.49e-05 | 469 | 100 | 8 | 27634302 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 6.66e-05 | 608 | 100 | 9 | 36089195 | |
| Pubmed | CENPN OBSCN SMURF1 LGR4 MAP3K3 INF2 TLR4 SERINC3 ESPL1 CNOT2 LRRC18 TP53BP1 | 6.68e-05 | 1084 | 100 | 12 | 11544199 | |
| Pubmed | 6.78e-05 | 472 | 100 | 8 | 38943005 | ||
| Pubmed | The histone methyltransferase MLL1 permits the oscillation of circadian gene expression. | 8.14e-05 | 5 | 100 | 2 | 21113167 | |
| Pubmed | 8.14e-05 | 5 | 100 | 2 | 20646321 | ||
| Pubmed | 8.14e-05 | 5 | 100 | 2 | 17118979 | ||
| Pubmed | 8.14e-05 | 5 | 100 | 2 | 22900038 | ||
| Pubmed | 8.14e-05 | 5 | 100 | 2 | 21864388 | ||
| Pubmed | 8.14e-05 | 5 | 100 | 2 | 25250834 | ||
| Pubmed | 8.14e-05 | 5 | 100 | 2 | 15905547 | ||
| Pubmed | TRIP12 and UBR5 suppress spreading of chromatin ubiquitylation at damaged chromosomes. | 8.14e-05 | 5 | 100 | 2 | 22884692 | |
| Pubmed | 8.60e-05 | 80 | 100 | 4 | 16094384 | ||
| Pubmed | CENPT EP400 TTC28 TOPBP1 TNRC6B ARHGAP11A MED19 KMT2A PRDM15 | 1.04e-04 | 645 | 100 | 9 | 25281560 | |
| Pubmed | 1.14e-04 | 653 | 100 | 9 | 22586326 | ||
| Pubmed | 1.22e-04 | 6 | 100 | 2 | 19318350 | ||
| Pubmed | BRCT repeats as phosphopeptide-binding modules involved in protein targeting. | 1.22e-04 | 6 | 100 | 2 | 14576432 | |
| Pubmed | 1.22e-04 | 6 | 100 | 2 | 19017981 | ||
| Pubmed | 1.22e-04 | 6 | 100 | 2 | 18398934 | ||
| Pubmed | Regulation of Legionella phagosome maturation and infection through flagellin and host Ipaf. | 1.22e-04 | 6 | 100 | 2 | 16984919 | |
| Pubmed | Sensing of commensal organisms by the intracellular sensor NOD1 mediates experimental pancreatitis. | 1.22e-04 | 6 | 100 | 2 | 22902233 | |
| Pubmed | 1.22e-04 | 6 | 100 | 2 | 21897371 | ||
| Pubmed | 1.22e-04 | 6 | 100 | 2 | 22033934 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | EP400 GNE UBE4B NOL6 CHD1 TEX10 DHX30 UBR5 INF2 SEC24B EXOC2 EPB41L2 TP53BP1 | 1.35e-04 | 1353 | 100 | 13 | 29467282 |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | 1.56e-04 | 533 | 100 | 8 | 30554943 | |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | 1.63e-04 | 536 | 100 | 8 | 15840001 | |
| Pubmed | 1.67e-04 | 538 | 100 | 8 | 10512203 | ||
| Pubmed | 1.70e-04 | 7 | 100 | 2 | 19933833 | ||
| Pubmed | 1.70e-04 | 7 | 100 | 2 | 11714696 | ||
| Pubmed | 1.70e-04 | 7 | 100 | 2 | 15669143 | ||
| Pubmed | 1.70e-04 | 7 | 100 | 2 | 17612494 | ||
| Pubmed | Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis. | 1.70e-04 | 7 | 100 | 2 | 18987631 | |
| Interaction | NUP43 interactions | CENPT EP400 RBBP6 NOL6 TOPBP1 TNRC6B CHD1 CCDC168 CUL7 TEX10 UBR5 SENP6 KMT2A KNL1 | 2.21e-06 | 625 | 99 | 14 | int:NUP43 |
| Interaction | SNRNP40 interactions | CENPT EP400 RBBP6 NOL6 CHD1 CUL7 TEX10 NCOA5 UBR5 SENP6 KMT2A EPB41L2 KNL1 | 1.42e-05 | 637 | 99 | 13 | int:SNRNP40 |
| Interaction | SLX4 interactions | EP400 TOPBP1 CHD1 ARHGAP11A TEX10 DHX30 UBR5 EIF2S3 SENP6 ZNF518B PCBP2 TP53BP1 | 2.38e-05 | 572 | 99 | 12 | int:SLX4 |
| Coexpression | FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP | 3.24e-06 | 164 | 100 | 7 | M19957 | |
| Coexpression | GSE8835_CD4_VS_CD8_TCELL_UP | 1.19e-05 | 200 | 100 | 7 | M6254 | |
| Coexpression | GSE21063_WT_VS_NFATC1_KO_BCELL_DN | 1.19e-05 | 200 | 100 | 7 | M8261 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_4|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 3.62e-06 | 183 | 100 | 6 | 3cbe0175d05fd39bc430de1ef471ff2c5b56460e | |
| ToppCell | Dividing_Macrophages-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.98e-06 | 186 | 100 | 6 | 0067eb78d4c7e32b9563550d9fcaf13445ee6a48 | |
| ToppCell | Control-Lymphoid-Proliferating_CD4_T_cells|Lymphoid / Condition, Lineage and Cell class | 5.22e-06 | 195 | 100 | 6 | 578bbb06a5476c08fc3b351cc580c551dfe53ae4 | |
| ToppCell | BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.37e-06 | 196 | 100 | 6 | 6d80e23f6a1725a3f5ea7263233c55c2ea56f977 | |
| ToppCell | BAL-Control-Myeloid-Myeloid|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.37e-06 | 196 | 100 | 6 | bf1d3fae8c01bb3d17c2dafad92b94937c663acd | |
| ToppCell | BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.37e-06 | 196 | 100 | 6 | 3dd7ed1dfac8d90c8a44f0ae00128bb46d9ef496 | |
| ToppCell | BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.37e-06 | 196 | 100 | 6 | 4f649e3bfd21f21682678828673843a7d51c4ff2 | |
| ToppCell | BAL-Control-Myeloid-Myeloid|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.37e-06 | 196 | 100 | 6 | 799c290fb3dfacb666dd0dc3c43ec8a86b697ec7 | |
| ToppCell | BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.37e-06 | 196 | 100 | 6 | 0c003a767c3b58605099dab64b9df0d8e5d8bc4b | |
| ToppCell | Control-Myeloid-proliferating_Myeloid_cells|Control / Disease group,lineage and cell class (2021.01.30) | 5.53e-06 | 197 | 100 | 6 | ddbe3fe078766bb55f0d7ca1aeb8f9e4aa696d8e | |
| ToppCell | Healthy_Control-Lymphoid-T-Proliferating_T|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 5.53e-06 | 197 | 100 | 6 | 3ce3dcbbe0edeb5a6fb5596dd6c2b4d6c1d5159d | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.53e-06 | 197 | 100 | 6 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast-MyoFB-1|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.91e-05 | 145 | 100 | 5 | ac41c6c02b7d78162b86222983688f54d04ac47d | |
| ToppCell | PND07-28-samps-Mesenchymal-Pericyte-pericyte_F|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.25e-05 | 150 | 100 | 5 | 2d0d6dc07dcfe28e3d7694c52d15d17dae2fd47b | |
| ToppCell | PND07-28-samps-Mesenchymal-Pericyte|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.25e-05 | 150 | 100 | 5 | 5b111ec11a642d63fafa7e1422e36f81a2776531 | |
| ToppCell | severe_influenza-NK_CD56bright|World / disease group, cell group and cell class (v2) | 2.55e-05 | 154 | 100 | 5 | 187b9d4eb0e98c506034735601ead480ff00bd57 | |
| ToppCell | severe_influenza-NK_CD56bright|severe_influenza / disease group, cell group and cell class (v2) | 2.80e-05 | 157 | 100 | 5 | fabaf54429dd5a899f9192f0d42522109ca36b9b | |
| ToppCell | PND01-03-samps-Myeloid-Macrophage-CD163+_Macrophage|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 3.06e-05 | 160 | 100 | 5 | 4480a7d6bd48d06b4e5196faac868f31ab7ed3ad | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.35e-05 | 163 | 100 | 5 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | E15.5-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.55e-05 | 165 | 100 | 5 | 8d3d5860a4785c4908160ae5fcb421ee80bd78ce | |
| ToppCell | E15.5-Endothelial-lymphatic_endothelial_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.55e-05 | 165 | 100 | 5 | 17ee6f269ed8d378465cf00ca59d48d8b106808e | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.55e-05 | 165 | 100 | 5 | fead3f2032f8fa5f7f0159a4434989b3d65debbb | |
| ToppCell | facs-Liver-Hepatocytes-24m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.65e-05 | 166 | 100 | 5 | 03a47b8687f54955e84df1edcb230db332c4ca8f | |
| ToppCell | Thalamus-Hematopoietic|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.65e-05 | 166 | 100 | 5 | 76d60ac7ac5d1eaf530f0c741d9c48e0bd58396b | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.98e-05 | 169 | 100 | 5 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(15)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.32e-05 | 172 | 100 | 5 | 7f3d0ef18f5df1ed80498d435b0378ca398c0b88 | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_proliferating_1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.32e-05 | 172 | 100 | 5 | 6fcc16f1067672967ecbcdfdc727649ae9891dd9 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.70e-05 | 175 | 100 | 5 | a154b28b0b2180652d51d4c7d804b3b81b35899e | |
| ToppCell | (01)_Cycling_Basal_(homeostasis)|World / shred by cell type and Timepoint | 4.96e-05 | 177 | 100 | 5 | 05c57578142a6662f18b294d5cc11e6efd6b0f8e | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_naive-8|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.96e-05 | 177 | 100 | 5 | 066e7500e7bdde88a7914f50a4661d8adf6db925 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.96e-05 | 177 | 100 | 5 | 68f1139fc378f351e3b9e9f392aacb150025bf03 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_3|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.09e-05 | 178 | 100 | 5 | 536a601abcc60867949ea06e9aafb6c7b799b56b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c03-MKI67|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.09e-05 | 178 | 100 | 5 | dbde3305e0c6a81593fe614e3f2e746b32cc16a7 | |
| ToppCell | Dividing_Macrophages-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 5.09e-05 | 178 | 100 | 5 | 1893fadac2ec3d5de0a641e57b7b2f962012a9ba | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.37e-05 | 180 | 100 | 5 | 5e1680088065be14447d5d5465f91f7edd071a1e | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.37e-05 | 180 | 100 | 5 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | IIH-cycling-|IIH / Condition, Cell_class and T cell subcluster | 5.51e-05 | 181 | 100 | 5 | 7f4fed9e296bc22cb5a1e6c8e3c4b641e97c3078 | |
| ToppCell | IIH-cycling|IIH / Condition, Cell_class and T cell subcluster | 5.51e-05 | 181 | 100 | 5 | ec3e782ce93dcfe1a54fb7284e4e39063614b0e2 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-F_(Ciliated)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.43e-05 | 187 | 100 | 5 | 88f785932e67c613db0dda84496de351359ed962 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-F_(Ciliated)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.43e-05 | 187 | 100 | 5 | 8896a00b30d11b90ca42726d4e122174a30b161b | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.59e-05 | 188 | 100 | 5 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.59e-05 | 188 | 100 | 5 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.59e-05 | 188 | 100 | 5 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.76e-05 | 189 | 100 | 5 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | Dividing_Macrophages-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 6.76e-05 | 189 | 100 | 5 | d4e88a3e50499d683e3db38aee04490146fe30bb | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.76e-05 | 189 | 100 | 5 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | Dividing_Macrophages-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 7.11e-05 | 191 | 100 | 5 | 3e567ed6b5fefafa7f460e49d25d60bb52a0a6c8 | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Dendritic-Cycling_Dendritic|bone_marrow / Manually curated celltypes from each tissue | 7.11e-05 | 191 | 100 | 5 | aa9c0b1b90cdb7a95d4e6332819f82cae0a79ff9 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.11e-05 | 191 | 100 | 5 | c8b99bd3a30c81ee4deba9cbf0196920ab3ab550 | |
| ToppCell | (3)_Macrophage_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 7.11e-05 | 191 | 100 | 5 | b42f0b89bb94fd43786ff50f1caeb3ebfbbb43fd | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.28e-05 | 192 | 100 | 5 | 27723f4e320e49d4a3daafa2d8d3946ff79fab64 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.28e-05 | 192 | 100 | 5 | 0a54c79dcfdeb99e3b512d42b22359618cfd17e9 | |
| ToppCell | Dividing_Macrophages-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 7.28e-05 | 192 | 100 | 5 | 741bd0c2b0a7ce3fcb1610ce8bdacaf9a803c212 | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 7.46e-05 | 193 | 100 | 5 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | Control-Lymphoid-Proliferating_CD4_T_cells|Control / Condition, Lineage and Cell class | 7.46e-05 | 193 | 100 | 5 | 33d409d6ed1c606337248587ad997ac5f67f081d | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.65e-05 | 194 | 100 | 5 | f39a471293ecc5c5967b00e772b8f48ebc9affbe | |
| ToppCell | 3'_v3-Lung-Myeloid_Mac-Cycling_Myeloid-Mac|Lung / Manually curated celltypes from each tissue | 7.65e-05 | 194 | 100 | 5 | a8ae49157ca3f9e8b3f1750a995aee012dc859b6 | |
| ToppCell | (1)_T_cells_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 7.65e-05 | 194 | 100 | 5 | 8f313071933451780309d2174ed27d8cdc734343 | |
| ToppCell | Control-Lymphoid_T/NK-T/NK_proliferative|Control / Disease group, lineage and cell class | 7.65e-05 | 194 | 100 | 5 | 9bbb124001fba7450f4639f47f9b720a483e7242 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.65e-05 | 194 | 100 | 5 | a75ecd0b0a928d4646602f7d16a645f6b3df3af5 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.65e-05 | 194 | 100 | 5 | 17744fd6645cf5a447a01a83f07e8d305c2bcd9c | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.65e-05 | 194 | 100 | 5 | e14f66f7584909621b776292fbd52808273fd2ee | |
| ToppCell | Dividing_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 7.83e-05 | 195 | 100 | 5 | 79ee423df85aa1631b7bdea74eacaf826dfc4a2c | |
| ToppCell | Dividing_cells-Dividing_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 7.83e-05 | 195 | 100 | 5 | 19829760dfcc0edafd2a2bd80f424a45d039af1f | |
| ToppCell | tumor_Lung-B_lymphocytes-GC_B_cells_in_the_DZ|B_lymphocytes / Location, Cell class and cell subclass | 7.83e-05 | 195 | 100 | 5 | 339e81a3a5b1f71c0d15ef1ef0f6999378704923 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.83e-05 | 195 | 100 | 5 | 926eb3fc5d028be936885bea0654a77db3107234 | |
| ToppCell | (1)_T_cells-(1)_T_cells_Dividing|(1)_T_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 7.83e-05 | 195 | 100 | 5 | cf00a0b4f341f0487d5b37810abe2952fdd3f6f2 | |
| ToppCell | Healthy/Control-T/NK_proliferative|Healthy/Control / Disease group and Cell class | 7.83e-05 | 195 | 100 | 5 | 957458fdc39723f4a31bd7fd3ce32891aa3fd462 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.83e-05 | 195 | 100 | 5 | 742c82c86487314cdb3178012004adb1164bcbdb | |
| ToppCell | mild-Lymphocytic-Prol._cells|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 7.83e-05 | 195 | 100 | 5 | 9a8cc9097a349fd0a53ccf2723ee8bb1418d6aca | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.83e-05 | 195 | 100 | 5 | a838bddeed487154791b69d27a68673783ff63c0 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.03e-05 | 196 | 100 | 5 | 73f951f7712e0aa3323676b9a4b7944d21d347c4 | |
| ToppCell | Healthy-T/NK_proliferative|Healthy / disease group, cell group and cell class | 8.03e-05 | 196 | 100 | 5 | 91e44aabb2e85dcc77ddae6f7e000118d45d1de6 | |
| ToppCell | Control-T/NK_proliferative|Control / Disease condition and Cell class | 8.03e-05 | 196 | 100 | 5 | 7b7bc25aef49bfd64f79303a92d527bf8188f7a6 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.22e-05 | 197 | 100 | 5 | 4b13335a43b9d6abc8e542e72440da7feb82fbe6 | |
| ToppCell | Healthy/Control-T/NK_proliferative|World / Disease group and Cell class | 8.22e-05 | 197 | 100 | 5 | 4a4d3083938783d6f5b87da02f10e501917da0b4 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic-lymphocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.22e-05 | 197 | 100 | 5 | 21861d8b389fafbdb7c3499684c9b6deee3dbd5e | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.22e-05 | 197 | 100 | 5 | 9b2c67de46bd59bf56c81a0d10b84cf4a041c120 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.22e-05 | 197 | 100 | 5 | 47be19f595135da248469b2e21b8d88f561827b2 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic-lymphocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.22e-05 | 197 | 100 | 5 | ffb004c37cdd26cb7cdcd80f769a2eded65416dc | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.42e-05 | 198 | 100 | 5 | 1fa213e79d828bff6465bde116536dd1b80d94e0 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_NK-Cycling_NK|lymph-node_spleen / Manually curated celltypes from each tissue | 8.42e-05 | 198 | 100 | 5 | b2868a897dd96494cf1829c30e0ce508f52efdf3 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating-cycling_dorsal_progenitors|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 8.42e-05 | 198 | 100 | 5 | 5f0964c3aa7e1dc52cbb46e754078920b65bcb88 | |
| ToppCell | (3)_DC_Monocyte_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 8.42e-05 | 198 | 100 | 5 | e2b89f6d7c0007ccab62495cd543fe0e5513a9a4 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 8.42e-05 | 198 | 100 | 5 | 629d674a9c9108c1acb3f7af57bbdbf34bb0528e | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-Undetermined|metastatic_Lymph_Node / Location, Cell class and cell subclass | 8.42e-05 | 198 | 100 | 5 | f9f083c76c51b6f014ecf80eaec957eff8d1ab75 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.42e-05 | 198 | 100 | 5 | c3dd887c95587f930b7afd32385627a9fa029ca4 | |
| ToppCell | medial-2-Hematologic-Proliferating_Macrophage|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.42e-05 | 198 | 100 | 5 | 64a2bcf5a9ba66a4fe08fbde33f1886c136cde8f | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.42e-05 | 198 | 100 | 5 | fcc14ac3eb5088b9d6cd6af5a34dee5b81c0ece8 | |
| ToppCell | distal-1-Hematologic-Proliferating_Macrophage|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.42e-05 | 198 | 100 | 5 | df3f5559ecd1f3cd1fd60e39dbad8741309e83a3 | |
| ToppCell | normal_Lymph_Node-T/NK_cells-Undetermined|T/NK_cells / Location, Cell class and cell subclass | 8.42e-05 | 198 | 100 | 5 | 47d572b9db2843aeb2079f33a852babf67270be4 | |
| ToppCell | distal-Hematologic-Proliferating_Macrophage-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.42e-05 | 198 | 100 | 5 | 8afeb1f9bc9d8551482c8fefe4c5f88d9cd13ee2 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.42e-05 | 198 | 100 | 5 | 48d39018c56ea8ba972c72af8ece10cbeb48fbc8 | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_proliferating_1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 8.42e-05 | 198 | 100 | 5 | 281fc2536cdc4c717b30de156e563c0e4baba99d | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_proliferating_1|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.42e-05 | 198 | 100 | 5 | f801157468e59b5d049f703feadc9bb0f11e85cc | |
| ToppCell | (1)_T_cell_dividing|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 8.42e-05 | 198 | 100 | 5 | dac3a16e3a070a37f4d0ea37633c23fdc8a9c70a | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.42e-05 | 198 | 100 | 5 | da6963184c32761c896a9b91a5321ad84b583736 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.62e-05 | 199 | 100 | 5 | 11c3d9fe811a4619347f47d2b0e94066e3085625 | |
| ToppCell | 15-Airway-Mesenchymal-Mesenchyme_RSPO2+|Airway / Age, Tissue, Lineage and Cell class | 8.62e-05 | 199 | 100 | 5 | 5c8b847b794b3e88722f5b841f2539a27251106c | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div1-28|World / Primary Cells by Cluster | 8.62e-05 | 199 | 100 | 5 | 787688b68ae5d8768c0a24673ae07ab07616764a | |
| Drug | Prednicarbate [73771-04-7]; Down 200; 8.2uM; PC3; HT_HG-U133A | 2.04e-06 | 193 | 99 | 8 | 5119_DN | |
| Disease | MEHMO syndrome (implicated_via_orthology) | 1.14e-05 | 2 | 100 | 2 | DOID:0060801 (implicated_via_orthology) | |
| Disease | glucose metabolism disease (implicated_via_orthology) | 1.16e-04 | 28 | 100 | 3 | DOID:4194 (implicated_via_orthology) | |
| Disease | hypopituitarism (implicated_via_orthology) | 1.69e-04 | 6 | 100 | 2 | DOID:9406 (implicated_via_orthology) | |
| Disease | Focal Segmental Glomerulosclerosis, Not Otherwise Specified | 4.03e-04 | 9 | 100 | 2 | C4049702 | |
| Disease | leukodystrophy (implicated_via_orthology) | 4.03e-04 | 9 | 100 | 2 | DOID:10579 (implicated_via_orthology) | |
| Disease | C-reactive protein measurement | SEMA6C UBE4B CCDC168 BCL3 CILP2 LRRC25 CCDC34 TREM2 KCNN3 IL4R CUX1 TP53BP1 | 7.86e-04 | 1206 | 100 | 12 | EFO_0004458 |
| Disease | serum albumin measurement | 9.25e-04 | 592 | 100 | 8 | EFO_0004535 | |
| Disease | phospholipids in VLDL measurement | 1.07e-03 | 59 | 100 | 3 | EFO_0022301 | |
| Disease | total lipids in small VLDL | 1.55e-03 | 67 | 100 | 3 | EFO_0022148 | |
| Disease | skin hydration measurement | 2.29e-03 | 21 | 100 | 2 | EFO_0009586 | |
| Disease | cerebellar cortex volume measurement | 2.29e-03 | 21 | 100 | 2 | EFO_0010291 | |
| Disease | Kidney Failure | 2.51e-03 | 22 | 100 | 2 | C0035078 | |
| Disease | Colorectal Carcinoma | 2.69e-03 | 702 | 100 | 8 | C0009402 | |
| Disease | late-onset Alzheimers disease | 3.21e-03 | 292 | 100 | 5 | EFO_1001870 | |
| Disease | physical activity | 3.36e-03 | 88 | 100 | 3 | EFO_0003940 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TLSHSQLRQLTAGQP | 1636 | Q96L91 | |
| LPLSGHSALSIQELV | 1106 | P39880 | |
| LPNSGHLLVQVTATL | 441 | Q8NEN0 | |
| RPIQNTSTSLHLELS | 216 | Q86SQ3 | |
| QQLSEDTLTIHGLPT | 196 | O95567 | |
| HRGNEVSTTPLLANS | 136 | Q9H9E1 | |
| HLLSSLQLLPNRTGS | 2596 | Q96M86 | |
| RPDNLSQTSLIHLSS | 96 | Q5VTE6 | |
| SSQVHPLAVLLLTDG | 1091 | Q7L2E3 | |
| HQLSTLVLTGNPLIF | 101 | Q99467 | |
| NHRLLITGTPLQNSL | 636 | O14646 | |
| LELNSSSSHNTLRPA | 236 | A7MBM2 | |
| LQHSLSTEPAVVLGL | 956 | A7MBM2 | |
| RGPSVLHNSVLSLSN | 816 | Q8TE58 | |
| GDIHTTLLSAVIPNA | 316 | Q96MZ0 | |
| GLRHPLSSTQAQTAT | 36 | Q5VVH5 | |
| LCSLPNTSLHGIRQL | 191 | Q9HB89 | |
| RTSTAHLLSLSQGPQ | 231 | O95872 | |
| LSSLLNKTTVHNIPG | 786 | Q9NVR5 | |
| RPTALINGHLNSLQS | 141 | P61968 | |
| SGLSLSLPHNQSLRA | 46 | Q8N386 | |
| RITPLSLQTQGSSHE | 671 | O43491 | |
| LTTSLAGSHPQLRAL | 1786 | Q9H6A9 | |
| NDTRPSVLGHLSQTA | 411 | Q96KP1 | |
| STAILHPSSRQGSQL | 116 | Q9UGI6 | |
| QIQSGILRLFSLPHS | 296 | Q9H340 | |
| TLIQSGPALSHLVSQ | 546 | Q9HCD5 | |
| QSLDTPETNRTLHLT | 671 | Q14999 | |
| TRQLPLLTSALHGLQ | 831 | Q9H6R4 | |
| PGSNILALVTQVSLH | 361 | Q8WVB3 | |
| LRNHPSLTTLSLASN | 836 | Q9Y239 | |
| VNLGLNHLDSVPTTL | 126 | Q8N456 | |
| HTLQILPATGNFSEI | 351 | Q8NG31 | |
| QFPNLTGTVHLESLT | 311 | Q9BXB1 | |
| PDGISTNTRLLNLHE | 71 | Q9HCJ2 | |
| QGLLHLEPTLRSSQL | 296 | Q27J81 | |
| TRFPSQTLLLSNQLH | 1456 | Q96JM4 | |
| TPSLLGQSLLHGQLI | 471 | Q7Z6E9 | |
| SELLQHGLPQISSRS | 656 | Q5TIA1 | |
| QTTSHELTIPNDLIG | 286 | Q15366 | |
| HQPSQEGLTLRLTIS | 2961 | Q5VST9 | |
| SGHLQVNTTLPARTL | 206 | P47804 | |
| QNILSHPISIRLGSF | 3436 | Q9C0G6 | |
| QGLTVPSNSHLVLVL | 1881 | Q14674 | |
| PGNLTVHTNVSDTLL | 126 | P24394 | |
| SIESLQIHLASTQGP | 331 | O00716 | |
| NSVDLRTPLSDTLHL | 496 | Q9Y223 | |
| NSTRSLLSPLGHQSF | 61 | Q96HJ3 | |
| QASGHLEEQTPRTLL | 76 | Q96BT3 | |
| GSQSQHSRLTLPRSL | 226 | P01880 | |
| HNSTTPLQERSLGLD | 216 | Q96H22 | |
| SNARTPLILIQTHGS | 3056 | Q0VDD8 | |
| TLPVLGTLDLSHNQL | 91 | P07359 | |
| HLPETGTTTDQLLRQ | 761 | Q5T7N3 | |
| PSLLDLGSLNTSSHR | 3266 | Q03164 | |
| LGSLNTSSHRTVPNI | 3271 | Q03164 | |
| GQPHLSRQDLTTLDV | 11 | Q2VIR3 | |
| LSHTQPTQIESLAEG | 2471 | Q8NDH2 | |
| GRSPLIHAVENNSLS | 276 | P20749 | |
| LTLHLQNTSTTRPVL | 501 | Q8NFJ9 | |
| TNTRETHSALGPALQ | 781 | O95487 | |
| HQGNLFTLVPSSRSL | 301 | Q99759 | |
| IDLPGSHDNSSLRSL | 116 | A0JLT2 | |
| HETLALLTSQLRPDS | 11 | Q13368 | |
| GAGQPTSHLVLTTLL | 836 | Q6ZUA9 | |
| LVGQSIHREPNLSLS | 841 | Q96J94 | |
| SGQDPNILLSHLLAR | 91 | O95399 | |
| SSLSPVLIGGNHLIT | 381 | Q6P4F7 | |
| GPLVSNLEITHTSNL | 221 | Q9UQF0 | |
| LGSPIQDVAITLHSL | 641 | Q969S9 | |
| GLLLIITPDSSHQNR | 271 | Q1RMZ1 | |
| LALQGLNPSRHTSAV | 221 | Q6ZSG1 | |
| GHLTTPERQLQLDNS | 1391 | P57071 | |
| TPLLRNSHSNSLISE | 1881 | Q8IVL1 | |
| HSPRNLILTSLQETG | 481 | Q9UKZ4 | |
| LSTLPSGLQENIIHL | 46 | P23515 | |
| LLQGHTSEPRDLNSV | 286 | Q9HCE7 | |
| LQTSRLLHGNPSTQL | 786 | O15516 | |
| ILHTSQSNTIPLGEL | 561 | Q8IUL8 | |
| LNRSLSQGTQLPSHV | 96 | Q9NZN8 | |
| SSPVILQFGHAETLL | 361 | Q9UNW1 | |
| SGLQNNTSPIIHSIL | 276 | Q96PX9 | |
| SHTALVLQGSLTQPR | 466 | O95155 | |
| ASHANFLLGIITIPT | 371 | Q9NPD5 | |
| HLGSRNPELSTQLID | 561 | Q9NXF1 | |
| HQPLLTLTSRALLTQ | 411 | Q9H3T2 | |
| ESTGPLLRTSIHQNS | 246 | Q9GZR1 | |
| PHLSDQVIGSQRSLS | 1826 | Q68DE3 | |
| SVPLHLSLTETQSQG | 686 | Q12888 | |
| QEHQPRSGLLQSSLI | 261 | Q13530 | |
| GTLTITLRNLQPHDA | 91 | Q9NZC2 | |
| LGAHDPQTTQELLTT | 341 | Q5R3I4 | |
| SSLIGQALTEILQHP | 1721 | Q96AY4 | |
| LSHLSTLILTGNPIQ | 101 | O00206 | |
| INLNSDTAEHPGTRL | 756 | Q92547 | |
| GESATLRSLLLNPHL | 96 | Q15649 | |
| VLHNLTPQIDGSTLR | 1651 | Q9UPQ9 | |
| ATNLVTLPNSRGEHL | 1261 | O95071 | |
| PLTKITSGHLSQQDL | 391 | Q96C45 | |
| SGRNLHSSSQQLLPF | 516 | Q9C0D4 | |
| GQPHLSRQDLTTLDV | 11 | P41091 | |
| GEPTSNITLLSLVHN | 116 | O94898 | |
| SLTLRLISGLPSLNH | 691 | Q14CX7 | |
| AFSLPGSTQHLRSQL | 1206 | Q5VU43 |